Antipodes Partners LTD I Rhythm Technologies, Inc. Transaction History
Antipodes Partners LTD
- $3 Billion
- Q2 2025
A detailed history of Antipodes Partners LTD transactions in I Rhythm Technologies, Inc. stock. As of the latest transaction made, Antipodes Partners LTD holds 255 shares of IRTC stock, worth $39,785. This represents 0.0% of its overall portfolio holdings.
Number of Shares
255Holding current value
$39,785% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IRTC
# of Institutions
298Shares Held
35.4MCall Options Held
128KPut Options Held
174K-
Vanguard Group Inc Valley Forge, PA3.11MShares$485 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.02MShares$471 Million1.14% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.81MShares$439 Million0.51% of portfolio
-
Black Rock Inc. New York, NY2.5MShares$390 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA2.2MShares$344 Million0.05% of portfolio
About iRhythm Technologies, Inc.
- Ticker IRTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 30,026,600
- Market Cap $4.68B
- Description
- iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platf...